AVERITAS
LIVE

Serial Number

97978838

Owner

Averitas Pharma, Inc.

Attorney

Paul C. Llewellyn

First Use Date

Nov 27, 2018

Filing Date

Dec 15, 2022

Add to watchlist:

No watchlists yet
View on USPTO

AVERITAS Trademark

Serial Number: 97978838 • Registration: 7771071

AVERITAS is a trademark filed by Averitas Pharma, Inc. on December 15, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Averitas Pharma, Inc. (15 trademarks)

Morristown, NJ 07960

Entity Type: 03

Trademark Details

Filing Date

December 15, 2022

Registration Date

April 22, 2025

First Use Anywhere

November 27, 2018

First Use in Commerce

March 29, 2019

Published for Opposition

March 28, 2023

Goods & Services

Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, and neurological diseases and disorders

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 22, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 22, 2025 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Apr 2, 2025 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Apr 2, 2025 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 1, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 1, 2025 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Apr 1, 2025 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Mar 21, 2025 GNFN
FINAL REFUSAL E-MAILED
Mar 21, 2025 GNFR
SU - FINAL REFUSAL - WRITTEN
Mar 21, 2025 CNFR
ASSIGNED TO LIE
Mar 15, 2025 ALIE
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 14, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 14, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 5, 2025 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Nov 20, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Nov 20, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 11, 2024 GNRN
NON-FINAL ACTION E-MAILED
Sep 11, 2024 GNRT
SU - NON-FINAL ACTION - WRITTEN
Sep 11, 2024 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Sep 5, 2024 SUPC
DIVISIONAL PROCESSING COMPLETE
Sep 5, 2024 DPCC
SOU EXTENSION 3 GRANTED
Sep 5, 2024 EX3G
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 8, 2024 TROA
ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST
Aug 8, 2024 INCD
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 7, 2024 AITU
ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST
Jun 10, 2024 INCD
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jun 4, 2024 AITU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 3, 2024 EXRA
USE AMENDMENT FILED
May 2, 2024 IUAF
DIVISIONAL REQUEST RECEIVED
May 2, 2024 DRRR
SOU EXTENSION 3 FILED
May 2, 2024 EXT3
TEAS REQUEST TO DIVIDE RECEIVED
May 2, 2024 ERTD
TEAS STATEMENT OF USE RECEIVED
May 2, 2024 EISU
SOU EXTENSION 2 GRANTED
May 2, 2024 EX2G
SOU EXTENSION 2 FILED
May 2, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
May 2, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 22, 2023 EXRA
SOU EXTENSION 1 GRANTED
Nov 20, 2023 EX1G
SOU EXTENSION 1 FILED
Nov 20, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 20, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 23, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 28, 2023 NPUB
PUBLISHED FOR OPPOSITION
Mar 28, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 8, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 21, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 21, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 21, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 21, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 21, 2023 CNEA
ASSIGNED TO EXAMINER
Feb 14, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 12, 2023 NWOS
NEW APPLICATION ENTERED
Dec 19, 2022 NWAP